N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide

C39H60N8O6 — CID 59665660

IUPACN-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide
SMILESCC(C)(C)[C@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(=O)N1CCN(CC2CCCCC2)[C@@H](C(=O)NC(CC2CCC2)C(=O)C(N)=O)C1
InChIInChI=1S/C39H60N8O6/c1-39(2,3)33(45-37(52)31(27-15-8-5-9-16-27)44-35(50)29-22-41-17-18-42-29)38(53)47-20-19-46(23-26-11-6-4-7-12-26)30(24-47)36(51)43-28(32(48)34(40)49)21-25-13-10-14-25/h17-18,22,25-28,30-31,33H,4-16,19-21,23-24H2,1-3H3,(H2,40,49)(H,43,51)(H,44,50)(H,45,52)/t28?,30-,31+,33-/m1/s1
InChIKeyYWESCKBBUIAKEI-BTVZMEPNSA-N
MW736.96 g/mol
LogP2.51
Rot. Bonds14

About N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide

N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide (PubChem CID 59665660) has the molecular formula C39H60N8O6 and a molecular weight of 736.96 g/mol. Its IUPAC name is N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide.

Molecular Properties

Compound NameN-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide
PubChem CID59665660
Molecular FormulaC39H60N8O6
Molecular Weight736.96 g/mol
Exact Mass736.46
IUPAC NameN-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide
SMILESCC(C)(C)[C@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(=O)N1CCN(CC2CCCCC2)[C@@H](C(=O)NC(CC2CCC2)C(=O)C(N)=O)C1
InChIInChI=1S/C39H60N8O6/c1-39(2,3)33(45-37(52)31(27-15-8-5-9-16-27)44-35(50)29-22-41-17-18-42-29)38(53)47-20-19-46(23-26-11-6-4-7-12-26)30(24-47)36(51)43-28(32(48)34(40)49)21-25-13-10-14-25/h17-18,22,25-28,30-31,33H,4-16,19-21,23-24H2,1-3H3,(H2,40,49)(H,43,51)(H,44,50)(H,45,52)/t28?,30-,31+,33-/m1/s1
InChIKeyYWESCKBBUIAKEI-BTVZMEPNSA-N
XLogP2.51
TPSA196.79 Ų
H-Bond Donors4
H-Bond Acceptors9
Rotatable Bonds14
Heavy Atoms53
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500736.96
LogP ≤ 52.51
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'diketo_group', 'substructure': 'N/A'}

Analyze N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide?
The IUPAC name of N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide (CID 59665660) is N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide.
What is the SMILES notation for N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide?
The canonical SMILES for N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide is CC(C)(C)[C@H](NC(=O)[C@@H](NC(=O)c1cnccn1)C1CCCCC1)C(=O)N1CCN(CC2CCCCC2)[C@@H](C(=O)NC(CC2CCC2)C(=O)C(N)=O)C1.
What is the InChIKey of N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide?
The InChIKey is YWESCKBBUIAKEI-BTVZMEPNSA-N. The full InChI is InChI=1S/C39H60N8O6/c1-39(2,3)33(45-37(52)31(27-15-8-5-9-16-27)44-35(50)29-22-41-17-18-42-29)38(53)47-20-19-46(23-26-11-6-4-7-12-26)30(24-47)36(51)43-28(32(48)34(40)49)21-25-13-10-14-25/h17-18,22,25-28,30-31,33H,4-16,19-21,23-24H2,1-3H3,(H2,40,49)(H,43,51)(H,44,50)(H,45,52)/t28?,30-,31+,33-/m1/s1.
What are the key properties of N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide?
N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide has a molecular weight of 736.96 g/mol, XLogP of 2.51, 14 rotatable bonds, 4 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1S)-2-[[(2S)-1-[(3R)-3-[(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)carbamoyl]-4-(cyclohexylmethyl)piperazin-1-yl]-3,3-dimethyl-1-oxobutan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]pyrazine-2-carboxamide is sourced from PubChem (CID 59665660), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).